MedPath

Multicentre study about therapie management, nutrient supply and long-term outcome of patients with mild hyperphenylalaninemia and classical phenylketonuria

Recruiting
Conditions
E70.0
E70.1
Classical phenylketonuria
Other hyperphenylalaninaemias
Registration Number
DRKS00004942
Lead Sponsor
niversität Leipzig
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with mild hyperphenylalaninemia or phenylketonuria

patients of both sexes with a minimum age of 4 year.

At the clinical/ study visit the patient is clinically healthy except for the mild hyperphenylalaninemia and phenylketonuria.

written informed consent of patient or and parents/ legal representative

Exclusion Criteria

-Inability to fulfill study criteria
-patients with psychiatric disorders
-epilepsy
-atypical phenylketonuria
-blood loss of more than 500 ml in the last three months
-severe allergic diathesis
-severe organic diseases
-acute diseases at the study visit, especially acute infections
-Every chronic disease or results of surgery of gestive tract which may affected resorption, metabolism or excretion (e.g. pancreatic insufficiency,
-Refusal to give consent
-Other metabolic disorders except for mild hyperphenylalaninemia and phenylketonuria
-Dystrophy (weight below the 5th percentile)
-Implementation of other diets except for the phenylalanine restricted diet
-Pregnancy or planned pregnancy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Metabolic control (as measured by dried blood phenylalanine concentrations – determinations means and range of variation)<br>Retrospective (max. 10 years ago) and prospective survey of dried blood phenylalanine concentrations of PKU patients regularly followed in the outpatient’s clinic in Leipzig<br><br>Determination of dried blood phenylalanine concentrations by liquid chromatography/<br>tandem mass spectrometry (LC-MS/MS)<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath